These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16298596)

  • 1. Benefits of early biopsy on the outcome of kidney transplantation.
    Dominguez J; Kompatzki A; Norambuena R; Arenas J; Dell'Oro A; Bustamante A; Pinochet R; Cabello JM; Alvarez S; Pais E; Llanos R; Cortes-Monroy G
    Transplant Proc; 2005 Oct; 37(8):3361-3. PubMed ID: 16298596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of biopsy in kidney transplants with delayed graft function and acute dysfunction.
    Silva DM; Garcia JP; Ribeiro AR; Veronese FJ; Edelweiss MI; Gonçalves LF; Manfro RC
    Transplant Proc; 2007 Mar; 39(2):376-7. PubMed ID: 17362734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathologic evaluation of pretransplant biopsy as a factor influencing graft function after kidney transplantation: a 1-year observation.
    Sulikowski T; Tejchman K; Domański L; Urasińska E; Kamiński M; Zietek Z; Sieńko J; Romanowski M; Safranow K; Bohatyrewicz R; Ciechanowski K; Ostrowski M
    Transplant Proc; 2007 May; 39(4):943-7. PubMed ID: 17524858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
    Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of early biopsy in kidney allograft recipients with delayed graft function.
    Puliatti C; Rizzello A; Ilham M; Asderakis A
    Transplant Proc; 2007; 39(6):1803-4. PubMed ID: 17692618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity.
    Diethelm AG
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):82-91. PubMed ID: 3515700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher graft salvage rate in renal allograft rupture associated with acute tubular necrosis.
    Sanchez de la Nieta MD; Sánchez-Fructuoso AI; Alcázar R; Pérez-Contin MJ; Prats D; Grimalt J; Blanco J
    Transplant Proc; 2004 Dec; 36(10):3016-8. PubMed ID: 15686684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic microangiopathy in renal transplant recipients treated with cyclosporin A.
    Zent R; Katz A; Quaggin S; Cattran D; Wade J; Cardella C; Zaltzman J; Fenton S; Cole E
    Clin Nephrol; 1997 Mar; 47(3):181-6. PubMed ID: 9105765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.
    El-Agroudy AE; El-Dahshan K; Mahmoud K; Ismail AM; El-Baz M; Shokeir AA; Ghoneim MA
    Exp Clin Transplant; 2008 Sep; 6(3):203-10. PubMed ID: 18954298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
    Morales JM; Andrés A; Dominguez-Gil B; Arriola M; Gutiérrez MJ; Hernández E; Ortuño T; Praga M
    Transplant Proc; 2005 Nov; 37(9):3738-42. PubMed ID: 16386523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed graft function in renal transplant recipients: risk factors and impact on 1-year graft function: a single center analysis.
    Bronzatto EJ; da Silva Quadros KR; Santos RL; Alves-Filho G; Mazzali M
    Transplant Proc; 2009 Apr; 41(3):849-51. PubMed ID: 19376369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the risk of chronic allograft dysfunction after renal transplantation in a randomized cyclosporine withdrawal trial.
    Hazzan M; Buob D; Labalette M; Provot F; Glowacki F; Hoffmann M; Copin MC; Noel C
    Transplantation; 2006 Sep; 82(5):657-62. PubMed ID: 16969289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine nephrotoxicity: how does it affect renal allograft function and transplant morphology?
    Morozumi K; Takeda A; Uchida K; Mihatsch MJ
    Transplant Proc; 2004 Mar; 36(2 Suppl):251S-256S. PubMed ID: 15041348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics in renal transplant recipients under treatment with cyclosporine and Myfortic.
    Brunet M; Crespo M; Millán O; Serón D; Torregrosa V; Jiménez O; Moreso F; Martorell J; Grinyo JM; Oppenheimer F
    Transplant Proc; 2007 Sep; 39(7):2160-2. PubMed ID: 17889124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is kidney graft biopsy indicated in recipients with newly developed, microscopic hematuria?
    Kim YS; Jeong HJ; Kim MS; Kim SI; Han DS; Park K
    Clin Transplant; 1998 Apr; 12(2):104-8. PubMed ID: 9575397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
    Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
    Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine-associated thrombotic microangiopathy in renal allografts.
    Zarifian A; Meleg-Smith S; O'donovan R; Tesi RJ; Batuman V
    Kidney Int; 1999 Jun; 55(6):2457-66. PubMed ID: 10354295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.